{"id":"https://openalex.org/W4296977039","doi":"https://doi.org/10.1007/s13555-022-00808-9","title":"Adverse-Event Reports in Over-the-Counter Topical Acne Drug Products Containing Benzoyl Peroxide from a Specific Pharmaceutical Company in the USA","display_name":"Adverse-Event Reports in Over-the-Counter Topical Acne Drug Products Containing Benzoyl Peroxide from a Specific Pharmaceutical Company in the USA","publication_year":2022,"publication_date":"2022-09-24","ids":{"openalex":"https://openalex.org/W4296977039","doi":"https://doi.org/10.1007/s13555-022-00808-9","pmid":"https://pubmed.ncbi.nlm.nih.gov/36152215","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9588102"},"language":"en","primary_location":{"id":"doi:10.1007/s13555-022-00808-9","doi":"https://doi.org/10.1007/s13555-022-00808-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-022-00808-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-022-00808-9.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s13555-022-00808-9.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038648247","display_name":"Lydia Szymanski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108170","display_name":"Galderma (United States)","ror":"https://ror.org/01rdxvn05","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108170","https://openalex.org/I4210163806"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lydia Szymanski","raw_affiliation_strings":["Galderma Laboratories, Fort Worth, TX, 76177, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma Laboratories, Fort Worth, TX, 76177, USA","institution_ids":["https://openalex.org/I4210108170"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015808449","display_name":"Krysten Lisella Arekapudi","orcid":"https://orcid.org/0000-0001-5905-2030","observed_orcids":["https://orcid.org/0000-0001-5905-2030"]},"institutions":[{"id":"https://openalex.org/I4210108170","display_name":"Galderma (United States)","ror":"https://ror.org/01rdxvn05","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108170","https://openalex.org/I4210163806"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Krysten Lisella Arekapudi","raw_affiliation_strings":["Galderma Laboratories, Fort Worth, TX, 76177, USA. krysten.arekapudi@galderma.com","Galderma Laboratories, Fort Worth, TX, 76177, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma Laboratories, Fort Worth, TX, 76177, USA. krysten.arekapudi@galderma.com","institution_ids":["https://openalex.org/I4210108170"]},{"raw_affiliation_string":"Galderma Laboratories, Fort Worth, TX, 76177, USA","institution_ids":["https://openalex.org/I4210108170"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5015808449"],"corresponding_institution_ids":["https://openalex.org/I4210108170"],"apc_list":{"value":6000,"currency":"USD","value_usd":6000},"apc_paid":{"value":6000,"currency":"USD","value_usd":6000},"fwci":0.484,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.52005712,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"12","issue":"11","first_page":"2397","last_page":"2400"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.49799999594688416,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.49799999594688416,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":0.4846000075340271,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzoyl-peroxide","display_name":"benzoyl peroxide","score":1.0},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7390000224113464},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.9150000214576721},{"id":"https://openalex.org/keywords/skin-irritation","display_name":"skin irritation","score":0.7760000228881836},{"id":"https://openalex.org/keywords/hypersensitivity","display_name":"hypersensitivity","score":0.9359999895095825},{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.8299999833106995},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C2778885487","wikidata":"https://www.wikidata.org/wiki/Q411424","display_name":"Benzoyl peroxide","level":4,"score":0.9326971173286438},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.9136497974395752},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.7291811108589172},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.65265291929245},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6151000261306763},{"id":"https://openalex.org/C2777988657","wikidata":"https://www.wikidata.org/wiki/Q66320","display_name":"Over-the-counter","level":3,"score":0.5659653544425964},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.47370025515556335},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4534643888473511},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24868330359458923},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.2104376256465912},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.13116389513015747},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.06158071756362915},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C44228677","wikidata":"https://www.wikidata.org/wiki/Q181898","display_name":"Polymerization","level":3,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1007/s13555-022-00808-9","doi":"https://doi.org/10.1007/s13555-022-00808-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-022-00808-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-022-00808-9.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},{"id":"pmid:36152215","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36152215","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and therapy","raw_type":"Letter"},{"id":"pmh:oai:pubmedcentral.nih.gov:9588102","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9588102/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatol Ther (Heidelb)","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s13555-022-00808-9","doi":"https://doi.org/10.1007/s13555-022-00808-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-022-00808-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-022-00808-9.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320325987","display_name":"Galderma","ror":"https://ror.org/05fswdm20"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4296977039.pdf","grobid_xml":"https://content.openalex.org/works/W4296977039.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W98550890","https://openalex.org/W198220418","https://openalex.org/W1502188917","https://openalex.org/W2276726626","https://openalex.org/W2947122756","https://openalex.org/W3160863307","https://openalex.org/W3207302795"],"related_works":["https://openalex.org/W7202364887","https://openalex.org/W4406371045","https://openalex.org/W4410051616","https://openalex.org/W2619743427","https://openalex.org/W2416031230","https://openalex.org/W86437769","https://openalex.org/W4391022599","https://openalex.org/W4399246765","https://openalex.org/W2140695247","https://openalex.org/W4411502271"],"abstract_inverted_index":{"Benzoyl":[0],"peroxide":[1],"(BPO)":[2],"has":[3],"been":[4],"used":[5,25],"extensively":[6],"in":[7,21,88],"dermatology,":[8],"often":[9],"for":[10],"the":[11,22,44,55,76,99],"treatment":[12],"of":[13,46,92,101],"acne":[14,104],"vulgaris.":[15],"In":[16],"a":[17,89],"20-year":[18],"period,":[19],"dermatologists":[20],"United":[23],"States":[24],"over-the-counter":[26],"BPO":[27,51,108],"more":[28],"than":[29],"13":[30],"million":[31],"times.":[32],"However,":[33],"skin":[34],"irritation":[35],"and":[36],"other":[37],"adverse":[38],"events":[39],"(AEs)":[40],"are":[41],"associated":[42,49],"with":[43,50],"use":[45],"BPO.":[47],"AEs":[48],"were":[52,73],"identified":[53],"using":[54],"Galderma":[56],"pharmacovigilance":[57],"system,":[58],"which":[59],"collects":[60],"AE":[61,71],"reports":[62,72],"from":[63,75,79],"multiple":[64],"sources.":[65],"Over":[66],"approximately":[67],"20":[68],"years,":[69],"558":[70],"collected":[74],"database,":[77],"ranging":[78],"application":[80],"site":[81],"reactions":[82],"to":[83],"systemic":[84],"hypersensitivity":[85],"reactions,":[86],"resulting":[87],"reporting":[90],"rate":[91],"under":[93],"1%.":[94],"These":[95],"data":[96],"show":[97],"that":[98],"risk":[100],"OTC":[102],"topical":[103],"drug":[105],"products":[106],"containing":[107],"is":[109],"low.":[110]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-09-25T00:00:00"}